Products

angelinsider

we identify stealth activity & newly launched tech startups in germany & switzerland, before anyone else.

angelinsider.de Data & Analytics / Market & Competitive Intelligence

AI Benchmark
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Nik
@imnikniklaus· 218 followers
Launched
2y ago
2024-01-31 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Show HN (1 pts)Launch

    Built a tool to track stealth activity and startup launches in D-A-CH

    Jan 31, 2024 · 2y agoLaunch page

  • Launched on Product HuntLaunch

    Identify new startups in the DACH region, before anyone else

    Jan 31, 2024 · 2y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered Unknown

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2024-01-31

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does angelinsider get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is angelinsider and what platforms does it support?
angelinsider is catalogued under Market & Competitive Intelligence: we identify stealth activity & newly launched tech startups in germany & switzerland, before anyone else. Supported platforms: Web.

Related products in this category

Data & Analytics / Market & Competitive Intelligence

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.